Devilee P - Search Results

1

Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.

Huijts PE, Vreeswijk MP, Kroeze-Jansema KH, Jacobi CE, Seynaeve C, Krol-Warmerdam EM, Wijers-Koster PM, Blom JC, Pooley KA, Klijn JG, Tollenaar RA, Devilee P, van Asperen CJ. Huijts PE, et al. Among authors: devilee p. Breast Cancer Res. 2007;9(6):R78. doi: 10.1186/bcr1793. Breast Cancer Res. 2007. PMID: 17997823 Free PMC article.

2

Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma.

Devilee P, van Vliet M, Bardoel A, Kievits T, Kuipers-Dijkshoorn N, Pearson PL, Cornelisse CJ. Devilee P, et al. Cancer Res. 1991 Feb 1;51(3):1020-5. Cancer Res. 1991. PMID: 1670997

3

[Cloning of the first gene for breast/ovarian cancer (BRCA1), mapping of a second gene locus (BRCA2) and consequences for clinical practice].

Oosterwijk JC, Devilee P, Meijers-Heijboer EJ, Menko FH, Klijn JG, Cornelisse CJ. Oosterwijk JC, et al. Among authors: devilee p. Ned Tijdschr Geneeskd. 1995 Mar 4;139(9):421-3. Ned Tijdschr Geneeskd. 1995. PMID: 7891762 Dutch. No abstract available.

4

[Initial Dutch results with a presymptomatic DNA tests in familial breast/ovarian carcinoma. Rotterdamse Werkgroep voor Erfelijke Tumoren].

Klijn JG, Devilee P, van Geel AN, Tilanus-Linthorst MM, Dudok-de Wit C, Meijers-Heijboer EJ. Klijn JG, et al. Among authors: devilee p. Ned Tijdschr Geneeskd. 1995 Mar 4;139(9):439-45. Ned Tijdschr Geneeskd. 1995. PMID: 7891765 Dutch.

5

Effect on a Dutch family of predictive DNA-testing for hereditary breast and ovarian cancer.

de Wit AC, Meijers-Heijboer EJ, Tibben A, Frets PG, Klijn JG, Devilee P, Niermeijer MF. de Wit AC, et al. Among authors: devilee p. Lancet. 1994 Jul 16;344(8916):197. Lancet. 1994. PMID: 7912795 No abstract available.

6

Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.

Bonsing BA, Devilee P, Cleton-Jansen AM, Kuipers-Dijkshoorn N, Fleuren GJ, Cornelisse CJ. Bonsing BA, et al. Among authors: devilee p. Cancer Res. 1993 Aug 15;53(16):3804-11. Cancer Res. 1993. PMID: 8101767

7

The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2.

Peelen T, Cornelis RS, van Vliet M, Petrij-Bosch A, Cleton-Jansen AM, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, Devilee P. Peelen T, et al. Among authors: devilee p. Eur J Hum Genet. 1996;4(4):225-30. doi: 10.1159/000472203. Eur J Hum Genet. 1996. PMID: 8875189

8

Genes responsible for familial breast cancer.

Cornelisse CJ, Cornelis RS, Devilee P. Cornelisse CJ, et al. Among authors: devilee p. Pathol Res Pract. 1996 Jul;192(7):684-93. doi: 10.1016/S0344-0338(96)80090-2. Pathol Res Pract. 1996. PMID: 8880869 Review.

9

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.

Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drüsedau M, Hogervorst FB, Hageman S, Arts PJ, Ligtenberg MJ, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, van 't Veer LJ, Bakker E, van Ommen GJ, Devilee P. Petrij-Bosch A, et al. Among authors: devilee p. Nat Genet. 1997 Nov;17(3):341-5. doi: 10.1038/ng1197-341. Nat Genet. 1997. PMID: 9354803 Free article.

10

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

Verhoog LC, Brekelmans CT, Seynaeve C, van den Bosch LM, Dahmen G, van Geel AN, Tilanus-Linthorst MM, Bartels CC, Wagner A, van den Ouweland A, Devilee P, Meijers-Heijboer EJ, Klijn JG. Verhoog LC, et al. Among authors: devilee p. Lancet. 1998 Jan 31;351(9099):316-21. doi: 10.1016/s0140-6736(97)07065-7. Lancet. 1998. PMID: 9652611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

429 results

Search Page